Migraine with aura: Conventional and non-conventional treatments

Neurological Sciences

Volumn 32, Issue SUPPL. 1, 2011, Pages

  D'Andrea, Giovanni ^a   Colavito, Davide ^a   Carbonare, Maurizio Dalle ^a   Leon, Alberta ^a  

^a Research and Innovation   (Italy)

Author keywords

Ginkgolide b; Lamotrigine; Migraine with aura; Picotamide; Treatments

Indexed keywords

ACETYLSALICYLIC ACID; ANTIEMETIC AGENT; BARBITURIC ACID DERIVATIVE; BUTALBITAL; BUTORPHANOL; CAFFEINE; CALCIUM ANTAGONIST; CODEINE; DICLOFENAC; DIHYDROERGOTAMINE; ERGOT ALKALOID; ERGOTAMINE; FLUNARIZINE; FLURBIPROFEN; HYPNOTIC AGENT; IBUPROFEN; KETAMINE; KETOROLAC; NAPROXEN; NARATRIPTAN; NIFEDIPINE; NIMODIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; UNINDEXED DRUG; ZOLMITRIPTAN;

ANXIETY; ARTICLE; ATAXIA; CLINICAL TRIAL (TOPIC); HUMAN; MIGRAINE WITH AURA; PATHOPHYSIOLOGY; PRIMARY HEADACHE; PROPHYLAXIS; SYMPTOMATOLOGY;

ANALGESICS; CLINICAL TRIALS AS TOPIC; HUMANS; MIGRAINE WITH AURA;

EID: 79960150123     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0529-0     Document Type: Article

References (66)

1. Launer LJ, Terwindt GM, Ferrari MD (1999) The prevalence and characteristics of migraine in a population based cohort: The GEM study. Neurology 53:537-542 (Pubitemid 29382048)
2. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(suppl 7):1-96
3. Stewart WF, Schechter A, Lipton RB (1994) Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology 44(suppl 4):24-39
4. Leao AAP (1944) Spreading depression of activity of cerebral cortex. J Neurophysiol 7:279-390
5. Olesen J, Larsen B, Luritzen M (1981) Focal hyperemia followed by spreading olegimia an impaired activation of rCBF in classic migraine. Ann Neurol 14:344-352 (Pubitemid 11106551)
6. D'Andrea G, Leon A (2010) Pathogenesis of migraine: From neurotransmitters to neuromodulators and beyond. Neurolo Sci 31(Suppl 1):S1-S7
7. Aurora KS, Cao Y, Bowyer SM, Welch KMA (1999) The occipital cortex is hyperexcitable inmigraine: Experimental evidences. Headache 39(7):469-476 (Pubitemid 29400297)
8. Lang E, Kaltenhauser M, Neundorfer B, Seidler S (2004) Hyperexcitability of the primary somatosensory cortex in migraine-a magnetoencephlographic study. Brain 127:2459-2469 (Pubitemid 39472974)
9. Welch KMA (1987) Migraine. A biobehavioral disorder. Arch Neurol 44:1899-1987
10. Mangano RM, Schwarcz R (1981) The human platelet as a model for the glutamatergic neuron: Platelt uptake of L-glutamate. J Neurochem 36(3):1067-1076 (Pubitemid 11100094)
11. D'Andrea G, Cananzi AR, Joseph R, Morra M, Zamberlan F, Ferro Milone F, Grunfeld S, Welch KMA (1991) Platelet glycine glutamate and aspartate in primary headache glutamate and aspartate in primary headache. Cephalalgia 11:197-200
12. Cananzi AR, D'Andrea G, Perini F, zamberlan F, Welch KMA (1995) Plasma and platelet levels of glutamate and glutamine in migraine with and without aura. Cephalagia 15:132-135
13. Prescot A, Becerra L, Pendse G, tully S, Burnstein R et al (2009) Excitatory neurotransmitters in brain regions in the interictal migraine patients. Mol Pain 5:34
14. D'Andrea G, Toldo M, Cortelazzo S, Ferro Milone F (1982) Platelet activity in migraine. Hedache 22:207-212 (Pubitemid 12016278)
15. D'Andrea G, Hasselmark L, Alecci M, Cananzi AR, Perini F, Welch KMA (1994) Platelet secretion from dense and a-granules in vitro in migraine with and without aura. J Neurol Neurosurg Psychiatry 57(5):557-561 (Pubitemid 24151246)
16. Joseph R, Welch KMA, D'Andrea G, Levine SR (1987) Sensitivity to PAF is increased inmigraine patients. Thromb Haemost 57:125
17. Sarchielli P, Alberti A, Coppola F, Baldi A, Gallai B, Floridi A, Capocchi G, Gallai V (2004) Platelet activating factor (PAF) in internal jugualr venous blood of migraine without aura assessed during migraine attacks. Cephalagia 24:623-630 (Pubitemid 39061251)
18. D'Andrea G, Cananzi AR, Perini F, Hasselmark L (1995) Platelet models and their possible usefulness in study of migraine pathogenesis. Cephalalgia 15:265-271
19. Anzola GP, Magoni M, Guindani M et al (1999) Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 52:1622-1625 (Pubitemid 29220637)
20. Carrerj S, Narbone MC, Zito C, serra S, Coglitore S, Pugliatti P, Luz Arrigo F, Oreto G (2003) Prevalence of atrial septum aneurysm in patients with migraine echocardiographic study. Headache 43((7):725-728 (Pubitemid 36993009)
21. D'Andrea G, Bonavita V, Rigamonti A, Bussone G (2003) Treatment of migraine with aura: Comments and prospectives. Neurol Sci 23:271-278 (Pubitemid 36336056)
22. Montagna P, Sacquegna T, Cortelli P, Lugaresi E (1989) Migraine as defect of brain oxidative metabolism: A hypothesis. J Neurol 236:124-125
23. Jensen K, Tfelt Hansen P, Lauritzen M, Olesen J (1985) Clinical trial of nimodipine for single attacks of classical migraine. Cephalalgia 5:125-131 (Pubitemid 15229130)
24. Goldner JA, Lewitt LP (1987) Treatment of complicated migraine with sublingual nifedipine. Headache 27:484-486 (Pubitemid 18092037)
25. Banerjee M, Findley LJ (1992) Sumatriptan in the treatment of acute migraine with aura. Cephalalgia 12:39-44
26. Bates D, Ashford E, Dowson R, Ensink FBM, Gilhus NE, Olesen J, Pilgrim AJ, Shvelin P (1994) Sumatriptan Aura Study Group. subcutaneous sumatriptan during the migraine aura. Neurology 44:1587-1592 (Pubitemid 24286630)
27. Hachinsky V, Norris JW, Edmeads J, Cooper PW (1978) Ergotamine and cerebral blood flow. Stroke 9:594-596 (Pubitemid 9018886)
28. Sanches del Rio M, Bakker D, O Wu et al (1999) Perfusion weighted imaging during migraine: Spontaneous visual aura and headache. Cephalalgia 19(8):701-707 (Pubitemid 29519412)
29. Henry PY, Larre P, Aupy M, Lafforgue JL, Orgogozo JM (1984) Reversible cerebral arteriopathy associated with the administration of ergot derivatives. Cephalalgia 4:171-178 (Pubitemid 14000015)
30. Kaube H, Herzog J, Kaufer T, Dichgans M, Diener HC (2000) Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 55:139-141 (Pubitemid 30461018)
31. Rozen DT (2000) Treatment of prolonged migrainous aura with intravenous furosemide. Neurology 55:732-733
32. Haan J, Sluis P, Sluis LH, Ferrari MD (2000) Acetazolamide treatment for migraine aura status. Neurology 55:1588-1589
33. Cologno D, Torelli P, Cademartiri C, Manzoni GC (2000) A prospective study of migraine with aura attacks in a headache clinic population. Cephalalgia 20(10):925-930 (Pubitemid 32336720)
34. Andersson PG, Dahl S, Hansen JH, Hansen PE, Hedman C, Nyagaard Kristensen T, de Fine Olivarius B (1983) Prophylactic treatment of classical and non classical migraine with metoprolol a comparison with placebo. Cephalalgia 3:207-212 (Pubitemid 14218426)
35. Kangasniemi P, Andersen AR, Andresson PG, Gilhus NE, Hedman C, Hultren M, Vilming S, Olesen J (1987) Classic migraine: Effective prophylaxis with metoprolol. Cephalalgia 7(4):231-238 (Pubitemid 18019581)
36. Kangasniemi P, Hedman C (1984) Metoprolol and propranolol in the prophylactic treatment of classical and common migraine: A double-blind study. Cephalalgia 4:91-96
37. Hedman C, Andressen AR, Andresson PG, Gilhus NE, Kangasniemi P, Olsson JE, Strandman E, Nestvold K, Olesen J (1988) Symptoms of classic migraine attacks: Modifications brought about by metoprolol. Cephalalgia 8:279-284 (Pubitemid 19028469)
38. Mentenopoulos G, Manafi TH, Logothetis J, Bostantzopoulou S (1985) Flunarizine in the prevention of classical migraine: A placebo-controlled evaluation. Cephalalgia 5(Suppl 2):134-140
39. D'Andrea G, Nordera GP (2006) Allais G Treatment of aura: Solving the puzzle Neurol Sci 27(Suppl 2):S96-S99 (Pubitemid 44390121)
40. D'Andrea G, Granella F, Cadaldini M, Manzoni GC (1999) Effectiveness of lamotrigine in the prophylaxis. Cephalalgia 19:64-66
41. Lampl C, Buzath A, Klinger D, Neumann K (1999) Lamotrigine in the prophylactic treatment of migraine with aura: A pilot study. Cephalalgia 19:58-63 (Pubitemid 29136853)
42. Chen WT, Fuh JL, Lu SR, Wang SJ (2001) Persistent migraineous visual phenomena might be responsive to lamotrigine. Headache 41:823-825
43. D'Andrea G, Granella F, Verdelli F (2002) Migraine with aura triggered by orgasm. Cephalalgia 22(6):485-486 (Pubitemid 36606070)
44. Pascual J, Caminero AB, Mateos V, Roig C, Leira R, Garcia-Monco C, Lainez MJ (2004) Preventing disturbing migraine with aura with lamotrigine: An open pilot study. Headache 44:1024-1028 (Pubitemid 39532346)
45. Lampl C, Katsarava Z, Diener HC, Limmroth V (2006) Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76:1730-1732
46. Steiner TJ, Findley LJ, Yeun AWC (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalagia 17:109-112 (Pubitemid 27166265)
47. White HS, Brown Sd, Woodhead JH, Skeen GA, Wolf HH (1997) Topiramate enhances GABA-mediated chloride flux and GABAevoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 28:167-179 (Pubitemid 27400459)
48. Cutrer FM (2001) Antiepileptic drugs: How they work in headache. Headache 41(Suppl 1):3-10
49. Lampl C, Bonelli S, Ramsmayr G (2004) Efficacy of topiramate in migraine with aura prophylaxis: Preliminary results of 12 patients. Headache 44:174-177 (Pubitemid 38233762)
50. Modesti PA, Colella A, Gensini G, Neri Serneri G (1989) Competitive inhibition of platelet thromboxane A2 receptor binding by picotamide. Eur J Pharmacol 169(1):85-93 (Pubitemid 19244952)
51. Allais G, D'Andrea G, Airola G, De Lorenzo C, Mana O, Benedetto C (2004) Picotamide in Migraine with aura prevention: A pilot study. Neurol Sci 25(Suppl 3):S267-S269 (Pubitemid 41462010)
52. Wang SJ, Chen HH (2005) Ginkgolide b, a constituent of Ginkgo Biloba, facilitates glutamate exocytosis from rat hippocampal nerve terminal. Eur J Pharmacol 514:141-149
53. Kuribara K, Wardlaw AJ, Moqbel R, Kay AB (1989) Inhibition of platelet-activating factor (PAF) banding to human eosinophils and neutrophils by specific Ginkgolide-derived PAF antagonist BN52021. J Allergy Clin Immunol 83:83-90 (Pubitemid 19052817)
54. Teather LA, Afonso VM, Wurtman RJ (2006) Inhibition of platelet-activating factor receptors in hippocampal plasma membranes attenuates the inflammatory nociceptive response in rats. Brain Res 1097(1):230-233 (Pubitemid 44041275)
55. Xia SH, Fang DC (2007) Pharmacological action and mechanism of ginlgolide. Clin Med J 120(10):922-928
56. Joseph R, Welch KM, D'Andrea G, Levine SR (1987) Sensitivity to PAF is increased inmigraine patients. Thromb Haemost 57(1):125
57. D'Andrea G, Hasselmak L, Alecci M, Cananzi AR, Perini F, Welch KMA (1994) Platelet secretion from dense and a-granules in vitro in migraine with and without aura. J Neurosurg Psychiatry 57(5):557-561 (Pubitemid 24151246)
58. Sarchielli P, Alberti A, Coppola F, Baldi A, Gallai B, Floridi A, Capecchi G, Gallai V (2004) Platelet-activating factor (PAF) in internal jugular venous blood of migraine with and without Aura patients assessed during migraine attacks. Cephalalgia 24:623-630 (Pubitemid 39061251)
59. Perini F, D'Andrea G, Galloni E et al (2005) Plasma cytochine levels in migraineurs and controls. Headache 45:926-931 (Pubitemid 41045371)
60. Yoshikawa T, Nalto Y, Kondo M (1999) Gingko biloba leaf extract: Review of biological action and clinical applications. Antioxid Redox Signal 1(4):469-480 (Pubitemid 129628310)
61. Welch KM, Nagesh V, Aurora SK et al (2001) Periacquetuctal gay matter disfunction in migraine: Cause or the burden of illness? Headache 7:629-637
62. Thompson AJ, Jarvis GE, Duke RK, Johnston GA, Lummis SC (2011) Gingkolide b and bilolabide block the pore of the 5-HT3 receptor at a location that overlap the picrotoxin binding site. Neuropharmacology 60(2-3):488-495
63. Faris LP, Eckert DE, Kim Suck-Von, Meller HW, Pardo VJ, Goodale LR, Hartman KB (2006) Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms. J Affect Disord 92:79-90
64. The International Classification of Headache Disorders (2004) 2nd edn. Cephalalgia 24(suppl-1):1-160
65. D'Andrea G, Bussone G, Allais G, Aguggia M, D'Onofrio F, Maggio M, Moschiano F, Saracco MG, Terzi MG, Peretta V, Benedetto C (2009) Efficacy of Ginkolide b in the Prophylaxis of migraine with aura. Neurol Sci 30(Suppl 1):S121-S124
66. Evers S, Afra J, Frese A, Goasdsby J, Linde M, May A, Sandor PS (2009) EFNS guideline on the drug treatment of migraine revised report of an EFNS task force. Eur J Neurol 16:968-998